OS and NRM after grade 2-4 and 3-4 aGVHD
| aGVHD . | UMC/PMC: CD4+ IR vs no CD4+ IR within first 100 d, % . | P . | MSK: CD4+ IR vs no CD4+ IR within first 100 d, % . | P . | UMC/PMC: CD4+ IR vs no CD4+ IR before aGVHD diagnosis, % . | P . |
|---|---|---|---|---|---|---|
| Grade 2-4 | ||||||
| NRM | 21 vs 43 | .04* | 5 vs 54 | .006** | 18 vs 34 | .006** |
| OS | 63 vs 48 | .13 | 61 vs 36 | .03* | 77 vs 48 | <.001*** |
| Grade 3-4 | ||||||
| NRM | 30 vs 80 | .02* | 5 vs 67 | .02* | 12 vs 74 | <.001*** |
| OS | 61 vs 20 | .04* | 75 vs 33 | .12 | 78 vs 24 | <.001*** |
| aGVHD . | UMC/PMC: CD4+ IR vs no CD4+ IR within first 100 d, % . | P . | MSK: CD4+ IR vs no CD4+ IR within first 100 d, % . | P . | UMC/PMC: CD4+ IR vs no CD4+ IR before aGVHD diagnosis, % . | P . |
|---|---|---|---|---|---|---|
| Grade 2-4 | ||||||
| NRM | 21 vs 43 | .04* | 5 vs 54 | .006** | 18 vs 34 | .006** |
| OS | 63 vs 48 | .13 | 61 vs 36 | .03* | 77 vs 48 | <.001*** |
| Grade 3-4 | ||||||
| NRM | 30 vs 80 | .02* | 5 vs 67 | .02* | 12 vs 74 | <.001*** |
| OS | 61 vs 20 | .04* | 75 vs 33 | .12 | 78 vs 24 | <.001*** |
Stratified by adequate CD4+ IR within first 100 d or before aGVHD diagnosis. Multivariate Cox proportional hazards models were applied.
P < .05, **P < .01, ***P < .001.